Zealand Pharma A/S | Key People and Executives
Jens Peter Stenvang
Director
Hanne Heidenheim Bak
Director
Alf Gunnar Martin Nicklasson
Chairman
Catherine Moukheibir
Independent Director
Rosemary A. Crane
Vice Chairman
Michael John Owen
Independent Director
Alain Munoz
Independent Director
Britt Meelby Jensen
President & Chief Executive Officer
Ivan Møller
Senior VP-Technical Development & Operations
Mats Blom
Chief Financial Officer & Executive Vice President
Andrew Parker
Chief Science Officer & Executive Vice President
Adam Steensberg
Chief Medical Officer & Senior Vice President
Christian Thorkildsen
Project Director
Helle Størum
Director-Business Development
Jens Peter Stenvang
Director
Hanne Heidenheim Bak
Director
Alette Pramming
Head-Communications
Alf Gunnar Martin Nicklasson
Chairman
Catherine Moukheibir
Independent Director
Rosemary A. Crane
Vice Chairman
Michael John Owen
Independent Director
Alain Munoz
Independent Director
| Address |
Smedeland 36
Glostrup ZE 2600
Denmark
|
|
Employees
|
- |
| Website |
http://www.zealandpharma.com |
| Updated |
07/08/2019 |
| Zealand Pharma A/S is a biotechnology company that engages in the discovery, design, and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark. |
